Cargando…
Therapeutic cancer vaccines: From biological mechanisms and engineering to ongoing clinical trials
Therapeutic vaccines are currently at the forefront of medical innovation. Various endeavors have been made to develop more consolidated approaches to producing nucleic acid-based vaccines, both DNA and mRNA vaccines. These innovations have continued to propel therapeutic platforms forward, especial...
Autores principales: | Sobhani, Navid, Scaggiante, Bruna, Morris, Rachel, Chai, Dafei, Catalano, Martina, Tardiel-Cyril, Dana Rae, Neeli, Praveen, Roviello, Giandomenico, Mondani, Giuseppina, Li, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9217071/ https://www.ncbi.nlm.nih.gov/pubmed/35759856 http://dx.doi.org/10.1016/j.ctrv.2022.102429 |
Ejemplares similares
-
The paradigm shift in treatment from Covid-19 to oncology with mRNA vaccines
por: Wei, Jiao, et al.
Publicado: (2022) -
p53 Antibodies as a Diagnostic Marker for Cancer: A Meta-Analysis
por: Sobhani, Navid, et al.
Publicado: (2021) -
Comparison of DNA vaccines with AS03 as an adjuvant and an mRNA vaccine against SARS-CoV-2
por: Neeli, Praveen, et al.
Publicado: (2023) -
C1QBP regulates mitochondrial plasticity to impact tumor progression and antitumor immune response
por: Wang, Qiping, et al.
Publicado: (2022) -
CTLA-4 in Regulatory T Cells for Cancer Immunotherapy
por: Sobhani, Navid, et al.
Publicado: (2021)